Literature DB >> 2112470

Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.

G Blomqvist1, S Pauli, L Farde, L Eriksson, A Persson, C Halldin.   

Abstract

A kinetic method is described for the estimation of neuroreceptor density as well as the rate constants for association and dissociation of rapidly equilibrating radioligands. The method is exemplified by positron emission tomographic measurements of the human brain using 11C-raclopride, a D 2 dopamine receptor antagonist, and 11C-Ro 15-1788, a benzodiazepine receptor antagonist. Using a linear non iterative algorithm, regional binding characteristics were calculated and displayed pixel by pixel in brain maps. Data from repeated experiments on the same subject with different amounts of the unlabeled ligand were utilized. The binding characteristics were determined according to a two step procedure in which the time course of the free radioligand concentration was estimated from a reference region considered to be free of specific receptor binding sites. Alternative methods to determine the concentration of free radioligand are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112470     DOI: 10.1007/bf00842777

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.

Authors:  J Logan; A P Wolf; C Y Shiue; J S Fowler
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

2.  Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches.

Authors:  S C Huang; J R Barrio; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1986-10       Impact factor: 6.200

3.  Strategies for in vivo measurement of receptor binding using positron emission tomography.

Authors:  J S Perlmutter; K B Larson; M E Raichle; J Markham; M A Mintun; M R Kilbourn; M J Welch
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

4.  Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.

Authors:  D F Wong; A Gjedde; H N Wagner
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

5.  Regional distribution of flunitrazepam binding constants: visualizing Kd and Bmax by digital image analysis.

Authors:  A W Toga; E M Santori; M Samaie
Journal:  J Neurosci       Date:  1986-09       Impact factor: 6.167

6.  On the construction of functional maps in positron emission tomography.

Authors:  G Blomqvist
Journal:  J Cereb Blood Flow Metab       Date:  1984-12       Impact factor: 6.200

7.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Authors:  M A Mintun; M E Raichle; M R Kilbourn; G F Wooten; M J Welch
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

8.  Head fixation device for reproducible position alignment in transmission CT and positron emission tomography.

Authors:  M Bergström; J Boëthius; L Eriksson; T Greitz; T Ribbe; L Widén
Journal:  J Comput Assist Tomogr       Date:  1981-02       Impact factor: 1.826

9.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

Authors:  L Farde; H Hall; E Ehrin; G Sedvall
Journal:  Science       Date:  1986-01-17       Impact factor: 47.728

10.  Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

Authors:  L Farde; S Pauli; H Hall; L Eriksson; C Halldin; T Högberg; L Nilsson; I Sjögren; S Stone-Elander
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  20 in total

1.  Nuclear medicine 2000.

Authors:  O Schober
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 3.  Pharmacological implications for neuroreceptor imaging.

Authors:  N P Verhoeff
Journal:  Eur J Nucl Med       Date:  1991

4.  Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography.

Authors:  Lia C Liefaard; Bart A Ploeger; Carla F M Molthoff; Ronald Boellaard; Adriaan A Lammertsma; Meindert Danhof; Rob A Voskuyl
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

5.  Closed-form kinetic parameter estimation solution to the truncated data problem.

Authors:  Gengsheng L Zeng; Grant T Gullberg; Dan J Kadrmas
Journal:  Phys Med Biol       Date:  2010-11-19       Impact factor: 3.609

6.  Estimating neurotransmitter kinetics with ntPET: a simulation study of temporal precision and effects of biased data.

Authors:  Marc D Normandin; Evan D Morris
Journal:  Neuroimage       Date:  2007-10-05       Impact factor: 6.556

7.  Initial comparison of ntPET with microdialysis measurements of methamphetamine-induced dopamine release in rats: support for estimation of dopamine curves from PET data.

Authors:  Evan D Morris; Marc D Normandin; Wynne K Schiffer
Journal:  Mol Imaging Biol       Date:  2008-01-04       Impact factor: 3.488

8.  Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI.

Authors:  S Pauli; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

9.  Characterization of [3H]nemonapride binding to mouse brain dopamine D2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies.

Authors:  K Ishiwata; K Inami; T Sasaki; T Nozaki; M Senda
Journal:  J Neural Transm Gen Sect       Date:  1994

10.  Benzodiazepine receptors mediate regional blood flow changes in the living human brain.

Authors:  E Matthew; P Andreason; K Pettigrew; R E Carson; P Herscovitch; R Cohen; C King; C E Johanson; D J Greenblatt; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.